Quality of surgery and treatment and its association with hospital volume : A population-based study in more than 5000 Belgian ovarian cancer patients
© 2024 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved..
BACKGROUND: Different sets of quality indicators are used to identify areas for improvement in ovarian cancer care. This study reports transparently on how (surgical) indicators were measured and on the association between hospital volume and indicator results in Belgium, a country setting without any centralisation of ovarian cancer care.
METHODS: From the population-based Belgian Cancer Registry, patients with a borderline malignant or invasive epithelial ovarian tumour diagnosed between 2014 and 2018 were selected and linked to health insurance and vital status data (n = 5119). Thirteen quality indicators on diagnosis and treatment were assessed and the association with hospital volume was analysed using logistic regression adjusted for case-mix.
RESULTS: The national results for most quality indicators on diagnosis and systemic therapy were around the predefined target value. Other indicators showed results below the benchmark: genetic testing, completeness of staging surgery, lymphadenectomy with at least 20 pelvic/para-aortic lymph nodes removed, and timely start of chemotherapy after surgery (within 42 days). Ovarian cancer care in Belgium is dispersed over 100 hospitals. Lower volume hospitals showed poorer indicator results compared to higher volume hospitals for lymphadenectomy, staging, timely start of chemotherapy and genetic testing. In addition, surgery for advanced stage tumours was performed less often in lower volume hospitals.
CONCLUSIONS: The indicators that showed poorer results on a national level were also those with poorer results in lower-volume hospitals compared to higher-volume hospitals, consequently supporting centralisation. International benchmarking is hampered by different (surgical) definitions between countries and studies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 50(2024), 3 vom: 15. März, Seite 107978 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bourgeois, Jolyce [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Healthcare quality indicator |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 11.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejso.2024.107978 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367962438 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367962438 | ||
| 003 | DE-627 | ||
| 005 | 20240311232217.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240203s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejso.2024.107978 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1323.xml |
| 035 | |a (DE-627)NLM367962438 | ||
| 035 | |a (NLM)38306864 | ||
| 035 | |a (PII)S0748-7983(24)00030-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bourgeois, Jolyce |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Quality of surgery and treatment and its association with hospital volume |b A population-based study in more than 5000 Belgian ovarian cancer patients |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 11.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved. | ||
| 520 | |a BACKGROUND: Different sets of quality indicators are used to identify areas for improvement in ovarian cancer care. This study reports transparently on how (surgical) indicators were measured and on the association between hospital volume and indicator results in Belgium, a country setting without any centralisation of ovarian cancer care | ||
| 520 | |a METHODS: From the population-based Belgian Cancer Registry, patients with a borderline malignant or invasive epithelial ovarian tumour diagnosed between 2014 and 2018 were selected and linked to health insurance and vital status data (n = 5119). Thirteen quality indicators on diagnosis and treatment were assessed and the association with hospital volume was analysed using logistic regression adjusted for case-mix | ||
| 520 | |a RESULTS: The national results for most quality indicators on diagnosis and systemic therapy were around the predefined target value. Other indicators showed results below the benchmark: genetic testing, completeness of staging surgery, lymphadenectomy with at least 20 pelvic/para-aortic lymph nodes removed, and timely start of chemotherapy after surgery (within 42 days). Ovarian cancer care in Belgium is dispersed over 100 hospitals. Lower volume hospitals showed poorer indicator results compared to higher volume hospitals for lymphadenectomy, staging, timely start of chemotherapy and genetic testing. In addition, surgery for advanced stage tumours was performed less often in lower volume hospitals | ||
| 520 | |a CONCLUSIONS: The indicators that showed poorer results on a national level were also those with poorer results in lower-volume hospitals compared to higher-volume hospitals, consequently supporting centralisation. International benchmarking is hampered by different (surgical) definitions between countries and studies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Healthcare quality indicator | |
| 650 | 4 | |a Hospital volume | |
| 650 | 4 | |a Neoplasm staging | |
| 650 | 4 | |a Ovarian epithelial carcinoma | |
| 650 | 4 | |a Ovarian neoplasms | |
| 700 | 1 | |a Peacock, Hanna M |e verfasserin |4 aut | |
| 700 | 1 | |a Savoye, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a De Gendt, Cindy |e verfasserin |4 aut | |
| 700 | 1 | |a Leroy, Roos |e verfasserin |4 aut | |
| 700 | 1 | |a Silversmit, Geert |e verfasserin |4 aut | |
| 700 | 1 | |a Stordeur, Sabine |e verfasserin |4 aut | |
| 700 | 1 | |a de Sutter, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Goffin, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Luyckx, Mathieu |e verfasserin |4 aut | |
| 700 | 1 | |a Orye, Guy |e verfasserin |4 aut | |
| 700 | 1 | |a Van Dam, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Van Gorp, Toon |e verfasserin |4 aut | |
| 700 | 1 | |a Verleye, Leen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology |d 1993 |g 50(2024), 3 vom: 15. März, Seite 107978 |w (DE-627)NLM01262862X |x 1532-2157 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2024 |g number:3 |g day:15 |g month:03 |g pages:107978 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejso.2024.107978 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2024 |e 3 |b 15 |c 03 |h 107978 | ||